FDA Approval: Uridine Triacetate for the Treatment of Patients Following Fluorouracil or Capecitabine Overdose or Exhibiting Early-Onset Severe Toxicities Following Administration of These Drugs.
Ison, Gwynn
FDA Approval: Uridine Triacetate for the Treatment of Patients Following Fluorouracil or Capecitabine Overdose or Exhibiting Early-Onset Severe Toxicities Following Administration of These Drugs. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Sep 2016 - 4545-9 p. digital
Publication Type: Journal Article; Review
1557-3265
10.1158/1078-0432.CCR-16-0638 doi
Acetates--chemistry
Animals
Antineoplastic Agents--chemistry
Capecitabine--administration & dosage
Clinical Trials as Topic
Drug Approval
Drug Evaluation, Preclinical
Fluorouracil--administration & dosage
Humans
Neoplasms--diagnosis
Prescription Drug Overuse
Research Design
Treatment Outcome
United States
United States Food and Drug Administration
Uridine--analogs & derivatives
FDA Approval: Uridine Triacetate for the Treatment of Patients Following Fluorouracil or Capecitabine Overdose or Exhibiting Early-Onset Severe Toxicities Following Administration of These Drugs. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Sep 2016 - 4545-9 p. digital
Publication Type: Journal Article; Review
1557-3265
10.1158/1078-0432.CCR-16-0638 doi
Acetates--chemistry
Animals
Antineoplastic Agents--chemistry
Capecitabine--administration & dosage
Clinical Trials as Topic
Drug Approval
Drug Evaluation, Preclinical
Fluorouracil--administration & dosage
Humans
Neoplasms--diagnosis
Prescription Drug Overuse
Research Design
Treatment Outcome
United States
United States Food and Drug Administration
Uridine--analogs & derivatives